Talk:PPAR agonist
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Requested move
[edit]- The following discussion is an archived discussion of the proposal. Please do not modify it. Subsequent comments should be made in a new section on the talk page. No further edits should be made to this section.
The result of the proposal was moved. --BDD (talk) 16:17, 3 April 2013 (UTC) (non-admin closure)
PPAR modulator → PPAR agonist – Why "modulator"? All the discussed substances are agonists AFAIK, and that's what the refs call them. ἀνυπόδητος (talk) 11:46, 27 March 2013 (UTC)
- Agreed. I say be bold and do it. SmartSE (talk) 11:00, 28 March 2013 (UTC)
- Support. --Arcadian (talk) 18:47, 28 March 2013 (UTC)
- The above discussion is preserved as an archive of the proposal. Please do not modify it. Subsequent comments should be made in a new section on this talk page. No further edits should be made to this section.
PPAR agonist
[edit]-Treatment of symptoms of metabolic syndrome, lowering triglycerides and blood sugar. -PPAR agonist(peroxisome proliferator activated receptor) 117.209.33.149 (talk) 14:45, 13 June 2024 (UTC)
